معرفی
Olle Melander is a Professor and Principal Investigator at Lund University, Department of Clinical Sciences, Malmö. He leads research teams in Cardiovascular Research - Hypertension, EpiHealth, EXODIAB, and MultiPark. His work focuses on identifying genetic, endocrine, and metabolic disturbances that precede diabetes-related cardiovascular disease (CVD) and testing interventions to mitigate these risks.
- Key discoveries include CVD genetic risk variants with pharmacogenomic implications
- Neurotensin's role in obesity and CVD
- Vasopressin as a modifiable CVD risk factor
His research integrates population cohorts, animal models, and human intervention trials. Recent work emphasizes genome-wide association studies and machine learning for risk prediction.
- Scientific Awards:
- Göran Gustafsson Prize (2016)
- Fernström Award (2013)
- Peter Sleight Award (2010)
- Lennart Hansson Memorial Fund (2006)
- Best Young Scientist (2005)
Professor Melander has supervised 38 PhD students and leads 10 active research projects, including Identification of Early Metabolic Disturbances (Swedish Heart Lung Foundation 2025-2028) and SEM2 (machine learning for emergency care). His team collaborates with SCAPIS and utilizes the Malmö Population-Based Cohorts Joint Database.
